カテゴリー： Transparency Market Research, 世界, 医療/バイオ

世界の整形外科用インプラント市場2022年ｰ2031年：製品別（関節再建、脊椎デバイス、外傷固定、生体材料、歯科用インプラント、その他）

◆英語タイトル：Orthopedic Implants Market (Product: Joint Reconstruction, Spinal Devices, Trauma Fixation, Orthobiologics, Dental Implants, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
	◆商品コード：TMR23JA081 ◆発行会社（リサーチ会社）：Transparency Market Research ◆発行日：2022年10月27日 ◆ページ数：226 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD5,795 ⇒換算￥869,250	見積依頼/購入/質問フォーム
Multi User（5名様閲覧）	USD8,795 ⇒換算￥1,319,250	見積依頼/購入/質問フォーム
Corporate License（法人閲覧）	USD11,795 ⇒換算￥1,769,250	見積依頼/購入/質問フォーム

★Transparency Market Researchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社は、世界の整形外科用インプラント市場について調査し、序論、仮定・調査手法、市場概要、主要インサイト、製品別（関節再建、脊椎デバイス、外傷固定、生体材料、その他）分析、エンドユーザー別（病院、整形外科クリニック、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況、企業情報などの内容を掲載しています。なお、当書に掲載されている企業情報には、Stryker、DePuy Synthes、Zimmer Biomet、Smith & Nephew、Orthopedic Implant Company、Medtronic Spinal、DJO Global、Arthrex, Inc.、NuVasive, Inc.、Evonikなどが含まれています。
・序論
・仮定・調査手法
・市場概要
・主要インサイト

・世界の整形外科用インプラント市場規模：製品別
- 関節再建インプラントの市場規模
- 脊椎デバイスの市場規模
- 外傷固定の市場規模
- 生体材料の市場規模
- その他製品の市場規模

・世界の整形外科用インプラント市場規模：エンドユーザー別
- 病院における市場規模
- 整形外科クリニックにおける市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模

・世界の整形外科用インプラント市場規模：地域別
- 北米の整形外科用インプラント市場規模
- ヨーロッパの整形外科用インプラント市場規模
- アジア太平洋の整形外科用インプラント市場規模
- 中南米の整形外科用インプラント市場規模
- 中東/アフリカの整形外科用インプラント市場規模

・競争状況
・企業情報

Orthopedic Implants Market – Scope of Report
TMR’s report on the global orthopedic implants market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global orthopedic implants market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global orthopedic implants market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the orthopedic implants market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global orthopedic implants market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global orthopedic implants market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global orthopedic implants market.

The report delves into the competitive landscape of the global orthopedic implants market. Key players operating in the global orthopedic implants market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global orthopedic implants market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market orthopedic implants.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthopedic Implants Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Orthopedic Implants Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key industry events (mergers & acquisitions, product launches, partnerships, etc.)
5.2. Technological advancements
5.3. Regulatory Scenario by Region/globally
5.4. Covid-19 Pandemic impact on the industry
6. Global Orthopedic Implants Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Joint Reconstruction
6.3.1.1. Hip Replacement
6.3.1.2. Knee Replacement
6.3.1.3. Shoulder Replacement
6.3.1.4. Others
6.3.2. Spinal Devices
6.3.2.1. Spinal Fusion Devices
6.3.2.2. Spinal Non-fusion Devices
6.3.3. Trauma Fixation
6.3.3.1. Metal Plates & Screws
6.3.3.2. Pins/Wires
6.3.3.3. Nails & Rods
6.3.3.4. Others
6.3.4. Orthobiologics
6.3.5. Dental Implants
6.3.6. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Orthopedic Implants Market Analysis and Forecast, by End user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End user, 2017–2031
7.3.1. Hospitals
7.3.2. Orthopedic Clinics
7.3.3. Ambulatory Surgery Centers
7.3.4. Others
7.4. Market Attractiveness Analysis, by End user
8. Global Orthopedic Implants Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Orthopedic Implants Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Joint Reconstruction
9.2.1.1. Hip Replacement
9.2.1.2. Knee Replacement
9.2.1.3. Shoulder Replacement
9.2.1.4. Others
9.2.2. Spinal Devices
9.2.2.1. Spinal Fusion Devices
9.2.2.2. Spinal Non-fusion Devices
9.2.3. Trauma Fixation
9.2.3.1. Metal Plates & Screws
9.2.3.2. Pins/Wires
9.2.3.3. Nails & Rods
9.2.3.4. Others
9.2.4. Orthobiologics
9.2.5. Dental Implants
9.2.6. Others
9.3. Market Value Forecast, by End user, 2017–2031
9.3.1. Hospitals
9.3.2. Orthopedic Clinics
9.3.3. Ambulatory Surgery Centers
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End user
9.5.3. By Country
10. Europe Orthopedic Implants Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Joint Reconstruction
10.2.1.1. Hip Replacement
10.2.1.2. Knee Replacement
10.2.1.3. Shoulder Replacement
10.2.1.4. Others
10.2.2. Spinal Devices
10.2.2.1. Spinal Fusion Devices
10.2.2.2. Spinal Non-fusion Devices
10.2.3. Trauma Fixation
10.2.3.1. Metal Plates & Screws
10.2.3.2. Pins/Wires
10.2.3.3. Nails & Rods
10.2.3.4. Others
10.2.4. Orthobiologics
10.2.5. Dental Implants
10.2.6. Others
10.3. Market Value Forecast, by End user, 2017–2031
10.3.1. Hospitals
10.3.2. Orthopedic Clinics
10.3.3. Ambulatory Surgery Centers
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End user
10.5.3. By Country/Sub-region
11. Asia Pacific Orthopedic Implants Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Joint Reconstruction
11.2.1.1. Hip Replacement
11.2.1.2. Knee Replacement
11.2.1.3. Shoulder Replacement
11.2.1.4. Others
11.2.2. Spinal Devices
11.2.2.1. Spinal Fusion Devices
11.2.2.2. Spinal Non-fusion Devices
11.2.3. Trauma Fixation
11.2.3.1. Metal Plates & Screws
11.2.3.2. Pins/Wires
11.2.3.3. Nails & Rods
11.2.3.4. Others
11.2.4. Orthobiologics
11.2.5. Dental Implants
11.2.6. Others
11.3. Market Value Forecast, by End user, 2017–2031
11.3.1. Hospitals
11.3.2. Orthopedic Clinics
11.3.3. Ambulatory Surgery Centers
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End user
11.5.3. By Country/Sub-region
12. Latin America Orthopedic Implants Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Joint Reconstruction
12.2.1.1. Hip Replacement
12.2.1.2. Knee Replacement
12.2.1.3. Shoulder Replacement
12.2.1.4. Others
12.2.2. Spinal Devices
12.2.2.1. Spinal Fusion Devices
12.2.2.2. Spinal Non-fusion Devices
12.2.3. Trauma Fixation
12.2.3.1. Metal Plates & Screws
12.2.3.2. Pins/Wires
12.2.3.3. Nails & Rods
12.2.3.4. Others
12.2.4. Orthobiologics
12.2.5. Dental Implants
12.2.6. Others
12.3. Market Value Forecast, by End user, 2017–2031
12.3.1. Hospitals
12.3.2. Orthopedic Clinics
12.3.3. Ambulatory Surgery Centers
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End user
12.5.3. By Country/Sub-region
13. Middle East & Africa Orthopedic Implants Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Joint Reconstruction
13.2.1.1. Hip Replacement
13.2.1.2. Knee Replacement
13.2.1.3. Shoulder Replacement
13.2.1.4. Others
13.2.2. Spinal Devices
13.2.2.1. Spinal Fusion Devices
13.2.2.2. Spinal Non-fusion Devices
13.2.3. Trauma Fixation
13.2.3.1. Metal Plates & Screws
13.2.3.2. Pins/Wires
13.2.3.3. Nails & Rods
13.2.3.4. Others
13.2.4. Orthobiologics
13.2.5. Dental Implants
13.2.6. Others
13.3. Market Value Forecast, by End user, 2017–2031
13.3.1. Hospitals
13.3.2. Orthopedic Clinics
13.3.3. Ambulatory Surgery Centers
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share/Ranking Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Stryker
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. DePuy Synthes
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Zimmer Biomet
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Smith & Nephew
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Orthopedic Implant Company
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Medtronic Spinal
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. DJO Global
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Arthrex, Inc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. NuVasive, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Evonik
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. Globus Medical
14.3.11.1. Company Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. Health Canada
14.3.12.1. Company Overview
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Strategic Overview
14.3.13. Kyocera Medical Technologies, Inc.
14.3.13.1. Company Overview
14.3.13.2. Product Portfolio
14.3.13.3. SWOT Analysis
14.3.13.4. Strategic Overview
14.3.14. Teijin Nakashima Medical Co., Ltd.
14.3.14.1. Company Overview
14.3.14.2. Product Portfolio
14.3.14.3. SWOT Analysis
14.3.14.4. Strategic Overview
14.3.15. HCM Orthocare Pvt. Ltd.
14.3.15.1. Company Overview
14.3.15.2. Product Portfolio
14.3.15.3. SWOT Analysis
14.3.15.4. Strategic Overview

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の整形外科用インプラント市場2022年ｰ2031年：製品別（関節再建、脊椎デバイス、外傷固定、生体材料、歯科用インプラント、その他）(Orthopedic Implants Market (Product: Joint Reconstruction, Spinal Devices, Trauma Fixation, Orthobiologics, Dental Implants, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の整形外科用インプラント市場2022年ｰ2031年：製品別（関節再建、脊椎デバイス、外傷固定、生体材料、歯科用インプラント、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp